Klencke Barbara — SEC Form 4 filings
SEC reporting owner CIK 1647647. 14 Form 4 filings on record with FilingPulse; latest filed 2026-07-08.
Transaction summary — filings shown
Covers all 14 filings on record, filed 2024-02-21 to 2026-07-08. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 3 legs across 2 filings — 15,000 shares, $82,550 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 15.
- Largest priced transaction: purchase of 5,000 shares @ $5.69 ($28,450) in TScan Therapeutics, Inc., filed 2024-08-27.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| TScan Therapeutics, Inc. (TCRX) | Director | 5 | 3 legs · 15,000 sh · $82,550 | — | 3 |
| Xencor Inc (XNCR) | Director | 3 | — | — | 6 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | Chief Medical Officer | 4 | — | — | 4 |
| eFFECTOR Therapeutics, Inc. (EFTR) | Director | 2 | — | — | 2 |
Form 4 filings — Klencke Barbara
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-08 | 4 | Xencor Inc (XNCR) | Grant/award (A): 10,302 @ $0 · Grant/award (A): 20,604 (derivative) @ $0 | EDGAR |
| 2026-05-22 | 4 | TScan Therapeutics, Inc. (TCRX) | Grant/award (A): 67,000 (derivative) @ $0 | EDGAR |
| 2026-04-17 | 4 | ALX ONCOLOGY HOLDINGS INC (ALXO) | Grant/award (A): 100,000 (derivative) @ $0 | EDGAR |
| 2026-03-05 | 4 | ALX ONCOLOGY HOLDINGS INC (ALXO) | Grant/award (A): 700,000 (derivative) @ $0 | EDGAR |
| 2025-09-19 | 4 | ALX ONCOLOGY HOLDINGS INC (ALXO) | Grant/award (A): 300,000 (derivative) @ $0 | EDGAR |
| 2025-07-02 | 4 | TScan Therapeutics, Inc. (TCRX) | Grant/award (A): 67,000 (derivative) @ $0 | EDGAR |
| 2025-06-16 | 4 | Xencor Inc (XNCR) | Grant/award (A): 13,686 @ $0 · Grant/award (A): 27,372 (derivative) @ $0 | EDGAR |
| 2025-01-23 | 4 | ALX ONCOLOGY HOLDINGS INC (ALXO) | Grant/award (A): 40,400 (derivative) @ $0 | EDGAR |
| 2024-09-24 | 4 | TScan Therapeutics, Inc. (TCRX) | Purchase (P): 5,000 @ $5.29 | EDGAR |
| 2024-08-27 | 4 | TScan Therapeutics, Inc. (TCRX) | Purchase (P): 5,000 @ $5.69 · Purchase (P): 5,000 @ $5.53 | EDGAR |
| 2024-06-17 | 4 | Xencor Inc (XNCR) | Grant/award (A): 5,986 @ $0 · Grant/award (A): 11,971 (derivative) @ $0 | EDGAR |
| 2024-06-14 | 4 | TScan Therapeutics, Inc. (TCRX) | Grant/award (A): 47,500 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | eFFECTOR Therapeutics, Inc. (EFTR) | Grant/award (A): 800 (derivative) @ $0 | EDGAR |
| 2024-02-21 | 4 | eFFECTOR Therapeutics, Inc. (EFTR) | Grant/award (A): 2,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1647647 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →